Latest Breaking News On - Juliane snowden - Page 1 : comparemela.com

XOMA to Present at H C Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ

XOMA to Present at H C Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKathy vincentJuliane snowdenRowen hughesBrad sitkoAnnual bioconnect investor conferenceExecutive teamChief executive officerChief investment officer

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Kathy vincentRowen hughesJuliane snowdenKinnate pharmaceuticalsDepartment of defenseSecurities exchangeCompany on linkedinExchange commissionAlora pharmaceuticalsDrug administrationFirst quarterHighlights recentDay oneChief executive officerDay one biopharmaceuticalPrescription drug user fee act

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Juliane snowdenBrad sitkoKathy vincentSecurities exchangeBioscience incExchange commissionDunn crutcherDrug administrationEconomic interestsThree first in category assetsMilestone portfolio includingVaginal gelSildenafil creamChief investment officerSecurities actSecurities exchange act

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Juliane snowdenKathy vincentRowen hughesExchange commissionDrug administrationSecurities exchangeAccelerated approvalDay onePediatric low grade gliomaDay one biopharmaceutical new drug applicationChief executive officerSecurities actSecurities exchange act

XOMA Corporation Announces Closing of Tender Offer

XOMA Corporation Announces Closing of Tender Offer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Wilson sonsini goodrich rosatiKathy vincentJuliane snowdenSecurities exchangeExchange commissionNasdaq stock marketCorporation announces closing of tenderKinnate biopharma incDunn crutcherAnnounces closingKinnate biopharmaCash amountPierre fabre laboratoriesExpiration dateSecurities exchange actLeerink partners